Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01477450 |
|
Recruitment Status :
Completed
First Posted : November 22, 2011
Results First Posted : September 26, 2014
Last Update Posted : September 26, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Hypoxemia Hypobaric Hypoxemia | Device: Pulse-dose oxygen Device: Cylinder oxygen delivery | Not Applicable |
Subjects will be monitored non-invasively with pulse oximetry, end-tidal carbon dioxide, tissue oxygenation and ECG. The mean seal level oxygen saturation will be recorded.Subjects exposed to an altitude of 14,000 feet will experience moderate hypobaric hypoxia. The mean oxygen saturation at this altitude is 83%. Subjects will receive oxygen from both an oxygen concentrator or a cylinder of oxygen following exposure to hypobarism. Oxygen from each source will be increased in 1 liter per minute increments until the oxygen saturation returns to the baseline sea level oxygen saturation.
The oxygen requirement to return oxygen saturation to baseline values will be recorded. The flow from the concentrator and the cylinder will be compared.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 30 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects |
| Study Start Date : | October 2011 |
| Actual Primary Completion Date : | March 2012 |
| Actual Study Completion Date : | September 2012 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: 1 L/min ; 16 mL
Cylinder oxygen delivery (1 L/min) followed by pulse-dose oxygen by concentrator (16 mL)
|
Device: Pulse-dose oxygen
Pulsed-dose oxygen delivery from an oxygen concentrator Device: Cylinder oxygen delivery Oxygen delivery from an oxygen cylinder |
|
Active Comparator: 2 L/min ; 32 mL
Cylinder oxygen delivery (2 L/min) followed by pulse-dose oxygen by concentrator (32 mL)
|
Device: Pulse-dose oxygen
Pulsed-dose oxygen delivery from an oxygen concentrator Device: Cylinder oxygen delivery Oxygen delivery from an oxygen cylinder |
|
Active Comparator: 3 L/min ; 48 mL
Cylinder oxygen delivery (3 L/min) followed by pulse-dose oxygen by concentrator (48 mL)
|
Device: Pulse-dose oxygen
Pulsed-dose oxygen delivery from an oxygen concentrator Device: Cylinder oxygen delivery Oxygen delivery from an oxygen cylinder |
- Return of Oxygen Saturation to Baseline (Sea Level) Values [ Time Frame: 50 minutes ]Oxygen will be titrated from either an oxygen concentrator or an oxygen cylinder in liters per minute until the oxygen saturation returns to the sea level value. The flow in liters per minute is the dependent variables. Each participant will experience induced hypoxemia followed by cylinder oxygen delivery; each will also experience induced hypoxemia followed by pulse-dose oxygen from a concentrator.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Current altitude chamber certification
- Age 18 years - 60 years
Exclusion Criteria:
- Current upper respiratory infection
- Current symptoms of lower respiratory infection -- productive cough
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01477450
| United States, Texas | |
| Brooks City Base | |
| San Antonio, Texas, United States, 78235 | |
| Principal Investigator: | Richard Branson, MSc RRT | University of Cincinnati |
| Responsible Party: | Rich Branson, M.D., Clinical Professor, University of Cincinnati |
| ClinicalTrials.gov Identifier: | NCT01477450 |
| Other Study ID Numbers: |
Branson-2010-02 |
| First Posted: | November 22, 2011 Key Record Dates |
| Results First Posted: | September 26, 2014 |
| Last Update Posted: | September 26, 2014 |
| Last Verified: | September 2014 |
|
Hypobaric hypoxemia Altitude Oxygen oxygen concentrator |
|
Hypoxia Signs and Symptoms, Respiratory |

